JP2002506072A5 - - Google Patents

Download PDF

Info

Publication number
JP2002506072A5
JP2002506072A5 JP2000535645A JP2000535645A JP2002506072A5 JP 2002506072 A5 JP2002506072 A5 JP 2002506072A5 JP 2000535645 A JP2000535645 A JP 2000535645A JP 2000535645 A JP2000535645 A JP 2000535645A JP 2002506072 A5 JP2002506072 A5 JP 2002506072A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
alkyloxy
carboxy
thieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000535645A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002506072A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK1999/000121 external-priority patent/WO1999046267A1/en
Publication of JP2002506072A publication Critical patent/JP2002506072A/ja
Publication of JP2002506072A5 publication Critical patent/JP2002506072A5/ja
Withdrawn legal-status Critical Current

Links

JP2000535645A 1998-03-12 1999-03-11 プロテインチロシンホスファターゼ(PTPase)のモジュレーター Withdrawn JP2002506072A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
DK0344/98 1998-03-12
DK34498 1998-03-12
DK0480/98 1998-04-03
DK48098 1998-04-03
DKPA199800938 1998-07-15
DKPA199801385 1998-10-28
DK199801612 1998-12-07
DK199800938 1998-12-07
DKPA199801612 1998-12-07
DK199801385 1998-12-07
PCT/DK1999/000121 WO1999046267A1 (en) 1998-03-12 1999-03-11 Modulators of protein tyrosine phosphatases (ptpases)

Publications (2)

Publication Number Publication Date
JP2002506072A JP2002506072A (ja) 2002-02-26
JP2002506072A5 true JP2002506072A5 (https=) 2006-04-27

Family

ID=27512769

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000535645A Withdrawn JP2002506072A (ja) 1998-03-12 1999-03-11 プロテインチロシンホスファターゼ(PTPase)のモジュレーター

Country Status (13)

Country Link
EP (1) EP1080095B1 (https=)
JP (1) JP2002506072A (https=)
KR (1) KR20010041814A (https=)
CN (1) CN1300291A (https=)
AT (1) ATE308546T1 (https=)
AU (1) AU2713599A (https=)
BR (1) BR9908726A (https=)
CA (1) CA2323493A1 (https=)
DE (1) DE69928100D1 (https=)
HU (1) HUP0104984A3 (https=)
IL (1) IL138319A0 (https=)
NO (1) NO20004527L (https=)
PL (1) PL342816A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4224566B2 (ja) 2000-12-18 2009-02-18 株式会社医薬分子設計研究所 炎症性サイトカイン産生遊離抑制剤
CN101103977A (zh) * 2002-06-05 2008-01-16 株式会社医药分子设计研究所 糖尿病治疗药
EP1512396A4 (en) * 2002-06-05 2008-12-31 Inst Med Molecular Design Inc HEMMER AGAINST ACTIVATION OF AP-1 AND NFAT
EA009701B1 (ru) 2002-06-06 2008-02-28 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Противоаллергические средства
CA2488363C (en) 2002-06-06 2011-01-04 Institute Of Medicinal Molecular Design, Inc. O-substituted hydroxyaryl derivatives
DK1753512T3 (da) * 2004-05-28 2008-11-17 4Sc Ag Tetrahydropyridothiophener
CA2568718A1 (en) * 2004-06-04 2005-12-15 Altana Pharma Ag Tetrahydropyridothiophenes for use in the treatment of cancer
CA2569623A1 (en) * 2004-06-11 2005-12-22 Altana Pharma Ag Novel compounds and use of tetrahydropyridothiophenes
LT2502911T (lt) * 2004-06-24 2017-09-11 Vertex Pharmaceuticals Incorporated Atp surišančios kasetės transporterių moduliatoriai
AU2006212224A1 (en) * 2005-02-09 2006-08-17 4Sc Ag Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
AU2006212179A1 (en) * 2005-02-11 2006-08-17 4Sc Ag Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer
WO2007031428A1 (en) * 2005-09-15 2007-03-22 F. Hoffmann-La Roche Ag 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
CN1939922B (zh) * 2005-09-27 2010-10-13 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的5H-噻吩[3,4-c]吡咯-4,6-二酮衍生物
SG10201510665WA (en) * 2009-12-04 2016-01-28 Sunovion Pharmaceuticals Inc Multicycle Compounds And Pharmaceutical Compositions Useful For The Treatment Of Neurological Disorders
CN102382076B (zh) * 2010-09-03 2016-08-17 中国医学科学院药物研究所 芳酮和芳酰胺类化合物及其制法和药物用途
CN102838625B (zh) * 2011-06-22 2015-04-15 中国科学院上海药物研究所 四氢吡啶并噻唑类化合物、其制备方法、包含该化合物的药物组合物及其用途
EP2948147B1 (en) * 2013-01-28 2019-03-13 H. Lundbeck A/S N-substituted-5-substituted phthalamic acids as sortilin inhibitors
CN106748999A (zh) * 2015-03-12 2017-05-31 佛山市赛维斯医药科技有限公司 一类含烟酸酰胺结构的ptp1b抑制剂、制备方法及其用途
CN104788424A (zh) * 2015-03-12 2015-07-22 佛山市赛维斯医药科技有限公司 含烟酸酰胺和哌啶结构的ptp1b抑制剂、制备方法及其用途
CN104788425A (zh) * 2015-03-12 2015-07-22 佛山市赛维斯医药科技有限公司 一类含烟酸酰胺和哌啶结构ptp1b抑制剂、制备方法及其用途
CN104725308A (zh) * 2015-03-12 2015-06-24 佛山市赛维斯医药科技有限公司 含烟酸酰胺结构的ptp1b抑制剂、制备方法及其用途
CN104829629B (zh) * 2015-03-26 2017-03-15 天津药物研究院有限公司 含磺酰胺基的四氢噻吩并[2,3‑c]吡啶衍生物、其制备方法和用途
MA45795A (fr) 2016-07-29 2019-06-05 Sunovion Pharmaceuticals Inc Composés et compositions, et utilisations associées
PT3494119T (pt) 2016-07-29 2024-12-10 Pgi Drug Discovery Llc Compostos e composições e seus usos
MX390141B (es) 2017-02-16 2025-03-20 Sunovion Pharmaceuticals Inc Metodos para tratar esquizofrenia
CA3070993C (en) 2017-08-02 2025-05-20 Sunovion Pharmaceuticals Inc. ISOCHROMANE COMPOUNDS AND THEIR USES
UA130249C2 (uk) 2018-02-16 2025-12-31 Сумітомо Фарма Америка, Інк. Солі, кристалічні форми і способи їх отримання
EP3938045A1 (en) 2019-03-14 2022-01-19 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
WO2020233645A1 (zh) 2019-05-21 2020-11-26 浙江海正药业股份有限公司 大环类衍生物、及其制备方法和用途
US11629130B2 (en) * 2020-04-14 2023-04-18 Purdue Research Foundation Lymphoid-specific tyrosine phosphatase (LYP) inhibitors
CA3180115A1 (en) 2020-04-14 2021-10-21 Sunovion Pharmaceuticals Inc. (s)-(4,5-dihydro-7h-thieno[2,3-c]pyran-7-yl)-n-methylmethanamine for treating neurological and psychiatric disorders

Similar Documents

Publication Publication Date Title
JP2002506072A5 (https=)
ES2645859T3 (es) Derivados de tienopiridina como inhibidores de MEK
ES2250167T3 (es) Derivados condensados de indol y su uso como ligandos del receptor 5ht, en particular 5ht2c.
ES2294047T3 (es) Un compuesto de ciclopenta (d) pirazolo(1,5-a) pirimidina como antagonista del receptor de crf.
AU726639B2 (en) Thienopyrimidines having PDE V-inhibiting action
ES2759510T3 (es) Compuestos tetracíclicos
WO2005023818A3 (en) Heterobicyclic compounds as pharmaceutically active agents
BRPI0714041A2 (pt) derivados de heteroaril substituìdos
HRP20110498T1 (hr) Azetidini kao inhibitori mek za liječenje proliferativnih bolesti
CA2521732A1 (en) Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
AR030306A1 (es) Derivados de piperazina, un procedimiento para su preparacion, composiciones farmaceuticas, un metodo para su fabricacion y el uso de dichos derivados para la fabricacion de un medicamento
JP2013539789A5 (https=)
GB0100621D0 (en) Chemical compounds VI
ES2323301T3 (es) Derivados de triazolo 4,5-d pirimidina y su uso como antagonistas del receptor purinergico.
SI9200105B (en) Imidazo(2,1-b)(3)benzazepine derivatives, compositions and method of use
ES2535490T3 (es) Preparación de moduladores de receptores 5-HT
HUP0100488A2 (hu) Tieno-pirimidinek, eljárás az előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
CN121127473A (zh) 作为wrn抑制剂的螺环衍生物
JP2005524669A (ja) グリコーゲンホスホリラーゼ阻害活性をもつ複素環式アミド誘導体
EP1657242A4 (en) imidazopyridine
AU743230B2 (en) Condensed thienopyrimidines with phosphodiesterase-V inhibiting action
RU96111027A (ru) Трициклические 5,6-дигидро-9h-пиразоло [3,4-c]-1,2,4-триазоло [4,3-a]пиридины
ES2498797T3 (es) Derivados de pirrolina contra la liberación en las células del factor de necrosis tumoral, sus métodos de preparación y sus usos
ES2304546T3 (es) Derivados de priridoindolona sustituidos en la posicion 3 con un fenilo, su preparacion y su aplicacion en terapeutica.
JP2004508330A5 (https=)